Autres langues Remedent, Inc.

Actions

REMI

US75954T1043

Marché Fermé - OTC Markets Autres places de cotation 15:40:02 17/06/2024			Varia. 5j.	Varia. 1 janv.
0,06 ^USD	+9,09 %		-.--%	-38,14 %

2023	Remedent, Inc. annonce ses résultats pour l'exercice clos le 31 mars 2023	CI
2022	Remedent, Inc. annonce ses résultats pour l'année complète se terminant le 31 mars 2022	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	22/11
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	20/09/22
Remedent : Attorney Letter - Lockett + Horwitz - Remedent, Inc. 2022-06-30 - re Annual Report	01/07/22
Remedent : Annual Report for Year Ended March 31, 2022	30/06/22
REMEDENT, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	30/06/21
Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies	30/06/21
Remedent announces its agreement with Aurum Ceramic Dental Laboratories Co., concerning an Exclusive Master License Agreement in reference to its GlamSmile Veneers and Technology	01/06/21
Remedent Announces Agreement with Aurum Ceramic Dental Laboratories Co., Concerning an Exclusive Master License Agreement in Reference to Its Glamsmile Veneers and Technology	01/06/21
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/02/21
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020	16/02/21
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020	16/11/20
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/11/20
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020	14/08/20
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/08/20
REMEDENT : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/06/20
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	30/06/20
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/02/20
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/02/20
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/11/19
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019	14/08/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Remedent, Inc.

Actions

REMI

US75954T1043

Autres langues

Filtres